Ride-sharing company Uber has hired two more leaders from the healthcare industry as the company continues to make a push in the space, CNBC reported.

The U.S. Department of Agriculture rolled out its final rule on school nutrition standards Dec. 6, allowing schools to ease up on whole grains, permanently serve 1 percent flavored milk and take their time reducing sodium levels in school lunches.

A new study published Dec. 7 in JAMA Network Open found that 29 percent of veterans who underwent recommended colonoscopy screening did not want to stop getting screened despite limited personal benefits.

A significant portion of healthcare workers are born outside the U.S., according to a new study published by Harvard Medical School researchers in JAMA.

RALEIGH, N.C., Dec. 7, 2018—Contego Medical announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its Vanguard IEP® Peripheral Balloon Angioplasty System with Integrated Embolic Protection.

REDWOOD CITY, Calif.—HeartFlow, Inc. today announced the start of the Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization (PRECISE) trial. The first patient was enrolled by Michael C. Turner, M.D., at Imperial Health Cardiovascular Specialists in Lake Charles, LA.

The Association of Community Cancer Centers (ACCC) and Pfizer Global Medical Grants will award more than $1.8 million in funding to 15 quality improvement (QI) projects aimed at improving BRCA genetic testing for eligible breast cancer patients.

Liraglutide was associated with a 10 percent reduction in major cardiovascular events for patients with type 2 diabetes in a real-world population, offering hope that the cardioprotective benefits observed in randomized trials translate to regular clinical practice.

The National Institutes of Health has awarded a $1.2 million grant for a project aimed at restoring voluntary movement in paralyzed limbs using AI.

PET imaging may hold promise for personalizing treatment in patients with tuberculosis meningitis (TBM), a rare disease that leaves some survivors with permanent brain damage, reported researchers from Johns Hopkins University School of Medicine in Baltimore.